|
HS Code |
983177 |
| Chemical Name | Isonicotinic Acid |
| Cas Number | 55-22-1 |
| Molecular Formula | C6H5NO2 |
| Molecular Weight | 123.11 g/mol |
| Appearance | White to off-white crystalline powder |
| Melting Point | 155-158 °C |
| Boiling Point | 263 °C (decomposes) |
| Solubility In Water | Moderately soluble |
| Pka | 4.82 |
| Density | 1.36 g/cm³ |
| Structure | Pyridine ring with carboxylic acid at 4-position |
| Smiles | C1=CC(=NC=C1)C(=O)O |
As an accredited Isonicotinic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Isonicotinic Acid, 250g, is packaged in a sealed, amber glass bottle with a tamper-evident cap and clear labeling. |
| Shipping | Isonicotinic Acid is shipped in tightly sealed containers, away from moisture and incompatible materials. It should be packaged in compliance with regulatory guidelines for chemical transport. Proper labeling and documentation are required, and storage during transit should ensure protection from physical damage, excessive heat, and direct sunlight to maintain product integrity. |
| Storage | Isonicotinic acid should be stored in a tightly closed container, in a cool, dry, and well-ventilated area away from incompatible substances such as strong oxidizers. Protect the chemical from moisture and direct sunlight. Ensure the storage area is equipped to contain spills, and use proper safety labeling. Store at room temperature to preserve stability and safety. |
Applications of Isonicotinic Acid in Industrial ManufacturingIsonicotinic acid is a pyridinecarboxylic acid applied in multiple advanced manufacturing sectors. As an upstream producer, we supply isonicotinic acid to industrial customers who require consistent purity and documented compliance to enable stringent quality control in complex formulations. Below, we present core industrial applications by specific sector. 1. Pharmaceutical API SynthesisPharmaceutical manufacturers use isonicotinic acid as a key intermediate in the synthesis of anti-tubercular agents and other pyridine-based active pharmaceutical ingredients (APIs). This compound enters the reaction scheme during heterocycle construction, especially in the production of nicotinic acid derivatives and antituberculosis drugs such as isoniazid. Strict oversight is maintained throughout the process for both purity and trace contaminants, supporting regulatory submission requirements. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Intermediate ManufacturingProducers in the crop protection industry incorporate isonicotinic acid as a building block for certain herbicides, fungicides, and plant growth regulators. The controlled carboxypyridine structure enables further chlorination, amidation, or esterification steps in multi-stage synthesis pathways. Batch and continuous agrochemical operations require traceability and hazard management adhering to sectoral regulations. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Metal Complexation and ElectroplatingCompanies in metal finishing employ isonicotinic acid as a ligand to form stable coordination complexes with metals like cobalt, nickel, and copper. These complexes serve as plating bath additives, improving deposit uniformity and adhesion on electronic component substrates or functionalized alloys. Critical process controls are set to monitor ligand concentration, pH, and solution conductivity during production scale-up. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Polymer Modifier and Resin AdditiveSpecialty polymer manufacturers use isonicotinic acid to introduce pyridine functionalities within advanced thermoplastic and thermoset resins. This improves certain engineering properties such as flame retardancy, chemical resistance, or polymer-ligand interaction for selective metal binding. The compound is usually integrated into the reaction mass during condensation or co-monomer addition stages in solvent or bulk processes. The traceability of additives is crucial for downstream audits and material certification. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Laboratory Reagent and Fine Chemical SynthesisChemical synthesis labs and contract research organizations utilize isonicotinic acid as a reagent or scaffold for developing novel ligands, catalysts, and organic building blocks. It supports route design for combinatorial chemistry, ligand screening, and coordination chemistry R&D. Purity, lot traceability, and consistent performance support regulatory filings and patent applications in the fine and specialty chemicals domain. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Isonicotinic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to sales7@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
In the world of specialty chemicals, few compounds anchor as many foundational processes as isonicotinic acid. Most people encounter it not as a name on a label, but as a molecular backbone supporting everything from advanced pharmaceuticals to reliable crop protection. From the start of our production journey to every drum leaving our facility, isonicotinic acid brings familiar challenges, subtle differences, and genuine value to the industries that lean on it.
Our isonicotinic acid, available under the model designation INA-99, keeps to a purity level above 99.5% by HPLC. As manufacturers, we lay special emphasis on consistent molecular integrity across runs. The compound’s structure – a pyridine ring substituting carboxylic acid at the 4-position – gives it distinct reactivity and selectivity compared to its isomers such as nicotinic acid (niacin). Unlike other pyridine carboxylic acids, INA-99 resists oxidation and retains compatibility with a wide set of organic and inorganic reagents. In practice, this means process chemists don’t struggle with unpredictable batch variability, especially when scaling up from pilot to plant.
Pharmaceutical synthesis demands traceability, batch record consistency, and above all a starting material that doesn’t shift under process conditions. Isonicotinic acid gives medicinal chemists a direct gateway to essential heterocycles and building blocks—hydrazides, amides, and esters keeping them at the edge of API synthesis. Take the example of isoniazid, a frontline anti-tuberculosis agent. The acid’s clean spectra and low metal ion content guarantee reproducible conversion, lowering downstream purification burdens. We track every kilo down to water content and residual solvents, holding water below 0.2% by KF and keeping heavy metals under 10ppm. That’s not paperwork, but the result of years addressing customer feedback and trace impurity issues.
Agriculture tells a different part of the story. Isonicotinic acid acts as a precursor for custom herbicides and plant growth regulators, supporting more productive yield while clocking a lower ecological footprint compared to alternatives. Because our synthesis limits by-products, downstream formulating teams see fewer unexpected interactions in finished blends. Reproducibility in moles and melting point may sound basic; the season doesn’t wait for inconsistencies to clear. If you’re tasked with pilot trials on a new formulation, having a source that matches specs every time determines success or failure; our process control keeps this in the producer’s hands.
The market offers nicotinic acid, picolinic acid, and even anthranilic acid, each targeting a related set of syntheses. The real-world difference comes down to reactivity at the carboxylic position. Isonicotinic acid, with its carboxyl at the 4-position, introduces less ring activation than picolinic acid. In downstream coupling, especially in amide formation, that position keeps side-reactions minimal, tightening yields and downstream purity. This property feeds directly into process economy—less reprocessing, fewer failures, and tighter batch rejections. Process chemists view these differences not in catalogs, but in labor hours and waste handling costs month after month.
Nicotinic acid shows labile behavior at the 3-position. Picolinic acid, with its 2-carboxylic placement, tends to chelate metals more aggressively, leading to headaches in certain catalysts or downstream reactions. We once received a report from a biotech client: batches made with misidentified isomer sources shifted major product lines out of spec, triggering weeks of troubleshooting. The switch to analytically certified isonicotinic acid restored their yields and cut their impurity problems by half. Real application, not theoretical advantage.
Consistency isn’t just a tagline. Our plant runs INA-99 under a batch process, keeping strict in-process checks: crystal morphology, residual sulfur, and color index measured throughout. By managing the oxidation state, especially during crystallization, we avoid both under-reacted intermediates and over-oxidized by-products. Every deviation links to a real-world headache—a dark spot under a microscope, a rejected incoming inspection from a pharmaceutical QA manager, or a solvent trace that jams a filling nozzle. Years of customer feedback teach that laboratory specifications rarely mirror shop floor realities, so we calibrate batch data against both HPLC purity and empirical handling metrics such as bulk density stability and filtration rates.
Shelf stability poses another issue. Many competitors market isonicotinic acid out of old storage or through extended backchannels. We handle internal storage under dry nitrogen and cycle inventory within ninety days, removing moisture and packaging contaminants as much as possible. Our packaging moves away from standard kraft sacks to polyethylene-lined drums, closing off cross-contamination and static absorption. When clients open a container, they report consistent flowability and no agglomerated lumps—a small but widely appreciated point in plant operations.
Any manufacturer in the chemical sector faces a rolling sequence of regulatory hurdles: REACH, TSCA, and several pharmaceutical compendia standards. We audit both internal processes and raw material supply chains, not just for compliance, but to anticipate shifts in accepted impurity profiles. For example, ongoing reviews around nitrosamine precursors forced a review of all our acid sources. We reworked one critical reduction step to eliminate a low-level by-product flagged in toxicological screening. This adjustment required months of re-optimization, but it preempted non-compliance once the stricter EU standards rolled out.
Pharmacopoeial monographs often define limits for related substances and residual metals, but in practical manufacturing, undocumented trace contaminants cause the biggest troubles. Our operations team devotes significant analytical time to tracking emerging “unknowns” in every batch, using mass spectrometry to match both published and as-yet unclassified signals. Where a suspected impurity trends up over several runs, we halt production for root-cause investigation and adjustment. This isn’t bureaucracy; it centers on avoiding recalls and protecting customer formulations against shifting regulatory baselines.
Nothing brings home the value of reliable isonicotinic acid like an unexpected production challenge. A client in the nutritional supplement field wrestled with residual solvents causing off-flavors after tableting. Reviewing their entire workflow showed all excipients above spec except ours—a result of refined drying and controlled crystallization making isonicotinic acid exceptionally low in volatiles. Another report came in from a research group scaling up a new plant growth control agent; their initial feedstock sourced from an offshore broker contained visible dark particles and trace off-odors. Our shipments, tightly controlled and freshly packed, cleared their particle tests and enabled full process qualification. These aren’t outliers; continuous improvements in our systems mean less troubleshooting on the user’s floor and more predictable application performance.
Sometimes the adjustment involves tighter controls on particle size, other times it means coordination around custom packaging or transport routes to reduce humidity ingress. We engage directly with user QA teams, sharing out-of-spec and field incident reports, keeping documentation accessible and clear. Every corrective action, from small tweaks in drying temperature to trace ion exclusion, translates to fewer calls for emergency shipments and late-stage re-batching. Quality ultimately lives where user and manufacturer communicate openly, and system fixes are built around feedback instead of checkboxes.
While the molecular structure stays constant, user demands and market trends keep shifting. Our R&D poured years into optimizing not just the original synthesis, but also refining purification and drying. We trialed over a dozen crystallization conditions before settling on the current form, which yields prismatic crystals that resist dusting but dissolve quickly on processing. While competitors ship re-crystallized product with undefined flow properties, we characterize our output for handling, even in high-humidity zones. Field use drives our data: we received repeated calls for product able to withstand shipment through Southeast Asia monsoons without caking—a result reached by deep dives into surface chemistry and packaging trials.
Cross-functional projects linking synthesis and packaging developed a tighter lid seal and oxygen barrier. No process stands still; last year’s data showed a spike in certain unknowns after suppliers altered their roasting profile on upstream pyridine. Our team quickly adjusted purification conditions, protecting the product’s analytical profile and keeping deliveries within spec. Direct technical support lines, staffed by chemists who know the plant, mean end users don’t waste time chasing theoretical consultants. We see recurring returns from research investment, not in patent slogans, but in the compliments from downstream engineers and operators finally able to trust every kilo received matches expectations.
Manufacturing isonicotinic acid inevitably generates process by-product streams. We take environmental stewardship as a baseline, not because it sells a brand, but because it shapes plant permitting, worker safety, and community relationships. Our facility invested early in closed-loop solvent recovery, reclaiming over 80% of mother liquors for internal reuse. Wastewater, often loaded with trace pyridine ring degradation products, runs through advanced catalytic oxidation before leaving our site. We monitor downstream discharge points and publish data; flat compliance records reflect years of investment and smart engineering, not luck.
Raw material selection reflects global volatility. Years ago, sudden price spikes in pyridine and related feedstocks risked process bottlenecks. We built out secondary supply agreements and maintain strategic on-site reserves, holding at least thirty days of average run inventory. Daily coordination between procurement, production, and logistics teams minimizes risk from late shipments or quality dips in incoming stocks. Downstream users, especially in pharmaceuticals, find assurance in upstream stability; they aren't left scrambling due to volatility in an overlooked precursor ingredient.
Industries evolve, and the application landscape for isonicotinic acid is expanding past legacy roles. Advanced materials research, diagnostics chemistry, and even electrochemical projects seek the unique properties of pyridine derivatives. We field queries from battery technologists looking at novel ligands; the structure and handling purity afforded by our INA-99 product open up new solution routes, supporting experimental chemistry not well-served by lower-grade material. Our technical team offers direct sample support, enabling rapid application testing and feedback cycles. These partnerships drive small-scale innovation without losing sight of the backbone demand from classical industries that built our expertise.
The movement toward greener chemistry also shapes process improvements. We’re exploring biocatalytic conversion routes and process intensification, not for marketing, but to shorten reaction times and cut solvent losses. Early stage results show promise, and we share pilot data with select partners under development agreements. Looking ahead, evolutionary steps in manufacturing technology—continuous processing, hybrid solvent systems, real-time impurity tracking—offer pathways toward even tighter product control and reduced environmental load. Each improvement depends on cooperation across the value chain, where reliable feedback and shared goals keep progress grounded in field reality.
Experience proves: every successful supply contract reflects more than a shipped invoice or analytical certificate. Reliable isonicotinic acid arrives clean, pure, and with supporting data that matches what users see in their own labs. Clients call us with positive results, but we learn most from challenges—the stories of sticky residues on a filter cake, the unexplained cloudiness in a critical crystallization, the rare off-odor batch in a sensitive application. Every incident prompts investigation, communication, and sometimes systemic changes to how we synthesize or package product. Over time, these small lessons aggregate into an operation that lives closer to its users, better at catching risks before they work their way into process bottlenecks or product recalls.
Competitive markets reward shortcuts in the short run, but for isonicotinic acid, decades of direct manufacturing experience prove the return on slow, steady investment in process control and honest quality assurance. As chemists, operators, and technical partners, we see the real-world effects of even the smallest deviations from standard—how they snowball into lost hours and wasted opportunity. We remain committed to pairing rigorous analytical discipline with open lines of communication, giving our partners more than just a list of specifications. Prompt feedback, transparent corrective actions, and continual sharing of improvements ground the trust that drives enduring commercial relationships.
As industry adoption grows across established and emerging sectors, our perspective as direct manufacturers keeps us focused on the metrics that matter—not just to us, but to every downstream engineer and operator relying on our product. From each small innovation on the plant floor to the anticipation of new regulatory or market demands, isonicotinic acid represents not just a chemical, but a promise of dependability. Here, meticulous manufacturing and customer-integrated feedback cycles produce more than consistency—they build partnership, ensuring every user receives quality that solves problems and drives new opportunity. The details matter. We make sure they line up every time.